Sunday 18 October 2026
Export DYNTQ’s income statement to Excel — free account
Dynatronics Corporation
DYNTQ Healthcare Medical Devices
Dynatronics Corporation’s revenue for fiscal 2025 (year ended June 2025) was $27.4 million, down 15.8% from fiscal 2024. In the quarter to September 2025, revenue fell 7.61%, EPS grew 66.7% and free cash flow fell 193.0%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow DYNTQ
| Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 | Jun '20 | Jun '19 | Jun '18 | Jun '17 | Jun '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 4 | 1 | 5 | 3 | 4 | 5 | 2 | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 20.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.02 | 0.02 | 0.07 | 0.25 | 0.39 | 0.17 | 0.22 | 0.30 | 0.25 | 0.26 |
Altman Z-Score |
(2.33) | (0.42) | (0.06) | 0.82 | 1.56 | 1.12 | 1.68 | 1.83 | 1.38 | 2.06 |
P/FCF ratio |
2.43 | 0.00 | 15.76 | 0.00 | 9.69 | 3.23 | 137.97 | 36.79 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(9.04) | (2.24) | (1.53) | 0.65 | 2.15 | 0.69 | 0.95 | 1.14 | 0.98 | 1.15 |
P/Operating CF |
7.74 | 3.08 | (87.45) | (6.70) | 268.89 | 16.70 | (11.43) | 29.72 | (11.41) | 58.75 |
Beneish M-Score |
(6.52) | (2.55) | (3.55) | (2.51) | (1.84) | (3.47) | (2.68) | (2.14) | 0.00 | (2.85) |
P/B ratio |
0.00 | 0.12 | 0.33 | 0.79 | 1.06 | 0.81 | 1.54 | 2.01 | 2.31 | 4.28 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 4.61 | 3.38 | 0.00 | 0.00 | 0.00 | 0.00 | 4.67 |
EV/Sales |
0.12 | 0.12 | 0.13 | 0.27 | 0.31 | 0.26 | 0.38 | 0.43 | 0.40 | 0.36 |
EV/EBITDA |
0.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 33.34 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
11.24 | (2.34) | 14.67 | (2.48) | 38.07 | 4.51 | 72.22 | 36.18 | (9.45) | (20.64) |
EV/FCF |
12.61 | (2.03) | 29.56 | (2.33) | 7.62 | 4.98 | 231.51 | 51.91 | (8.95) | (15.11) |
Quick Ratio |
0.41 | 0.58 | 0.54 | 0.66 | 1.55 | 0.94 | 0.54 | 0.66 | 0.73 | 1.14 |
Current Ratio |
1.09 | 1.37 | 1.56 | 1.94 | 2.47 | 2.09 | 1.40 | 1.47 | 1.76 | 2.48 |
Net Debt/EBITDA |
0.49 | (2.69) | (0.70) | (0.36) | 1.74 | (3.56) | 13.47 | (542.55) | (5.06) | (2.66) |
Debt/Assets |
20.11% | 13.69% | 10.29% | 5.49% | 5.82% | 19.19% | 24.62% | 23.13% | 22.53% | 26.01% |
Debt/Equity |
0.95 | 0.25 | 0.18 | 0.09 | 0.09 | 0.36 | 0.47 | 0.46 | 0.48 | 0.71 |
Asset Turnover |
1.32 | 1.16 | 1.24 | 1.19 | 1.25 | 1.38 | 1.53 | 1.89 | 1.73 | 1.77 |
Operating CF/Net income |
(0.03) | 0.47 | (0.07) | 1.03 | 0.32 | (0.72) | (0.19) | (0.22) | 0.36 | 0.24 |
Capex/Depreciation |
0.00 | (0.21) | (0.16) | (0.25) | 1.03 | (0.18) | (0.15) | (0.19) | (0.15) | (0.35) |
Interest Coverage |
(5.99) | (5.44) | (41.01) | (32.14) | (17.44) | (6.87) | (1.55) | (2.92) | (6.03) | (5.86) |
| (1,588.36%) | (45.55%) | (50.14%) | (30.25%) | 8.44% | (42.66%) | (18.21%) | (51.61%) | (150.56%) | (83.35%) | |
| (56.08%) | (12.24%) | (17.30%) | (12.68%) | 3.15% | (11.18%) | (4.20%) | (10.27%) | (20.77%) | (13.21%) | |
ROIC |
(25.59%) | (8.27%) | (15.63%) | (12.96%) | (10.91%) | (7.54%) | (1.64%) | (2.66%) | (5.83%) | (12.33%) |
Return on Tangible Assets |
(519.88%) | (71.10%) | (81.78%) | (38.74%) | 7.67% | (32.37%) | (15.17%) | (27.58%) | (39.73%) | (21.46%) |
Average Days of Receivables |
39.80 | 43.74 | 33.81 | 48.26 | 52.27 | 33.46 | 43.73 | 45.10 | 54.25 | 42.42 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.02% | 3.52% |
Selling, General and Administrative Expense of Revenue |
30.90% | 30.45% | 36.94% | 34.80% | 34.83% | 33.87% | 31.92% | 33.64% | 33.84% | 36.10% |
Intangible Assets out of Total Assets |
0.09 | 0.39 | 0.36 | 0.32 | 0.31 | 0.34 | 0.34 | 0.34 | 0.27 | 0.01 |
Share Based Compensation of Revenue |
0.01% | 0.00% | 0.32% | 0.40% | 0.32% | 0.52% | 0.48% | 0.40% | 1.17% | 0.67% |
Graham Net Nets |
(4.96) | (1.62) | (0.27) | 0.50 | 0.39 | (0.18) | 0.07 | 0.04 | (0.03) | 0.01 |
Graham Number |
4.29 | 0.00 | 0.00 | 0.00 | 6.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(1,762.50%) | (413.68%) | (194.67%) | (42.62%) | 5.00% | (46.90%) | (11.76%) | (18.16%) | (44.29%) | (27.61%) |
Free Cash Flow Yield |
41.20% | (246.23%) | 6.34% | (47.76%) | 10.32% | 30.97% | 0.72% | 2.72% | (18.29%) | (9.09%) |
Revenue per Share |
3.37 | 9.51 | 10.49 | 12.42 | 15.46 | 26.02 | 37.94 | 48.64 | 56.72 | 56.19 |
Operating CF per Share |
0.04 | (0.47) | 0.10 | (1.37) | 0.12 | 1.51 | 0.20 | 0.58 | (2.42) | (0.99) |
Capex per Share |
0.00 | (0.07) | (0.05) | (0.09) | 0.50 | (0.14) | (0.14) | (0.17) | (0.14) | (0.36) |
Free Cash Flow per Share |
0.03 | (0.54) | 0.05 | (1.46) | 0.62 | 1.36 | 0.06 | 0.40 | (2.56) | (1.35) |
Cash per Share |
0.05 | 0.16 | 0.14 | 0.20 | 2.02 | 1.13 | 0.16 | 1.28 | 0.40 | 1.79 |
Shareholders Equity per Share |
0.40 | 4.14 | 4.35 | 6.08 | 8.25 | 9.69 | 12.59 | 16.14 | 19.55 | 10.33 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.40 | 4.14 | 4.35 | 6.08 | 8.25 | 9.69 | 12.59 | 16.14 | 19.55 | 10.33 |
Free Cash Flow |
0.27 | (1.85) | 0.18 | (5.20) | 1.91 | 2.80 | 0.10 | 0.53 | (1.61) | (0.73) |
Working Capital |
0.72 | 2.85 | 4.48 | 9.29 | 12.43 | 8.40 | 5.64 | 6.84 | 5.83 | 5.82 |
Capital Expenditures |
(0.03) | (0.24) | (0.19) | (0.32) | 1.53 | (0.29) | (0.22) | (0.23) | (0.09) | (0.20) |
Net Current Asset Value |
(3.22) | (1.22) | (0.79) | 5.49 | 7.28 | (1.63) | 1.04 | 0.74 | (0.27) | 0.07 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.01 | 0.00 | 0.01 | (0.03) | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
5.33 | 0.59 | 0.49 | 0.44 | 0.44 | 0.33 | 0.26 | 0.21 | 0.11 | 0.12 |
Cash ROIC |
4.01% | (10.16%) | 0.90% | (21.37%) | 5.62% | 9.51% | 0.33% | 1.62% | (8.75%) | (6.94%) |
Accounts Receivable Turnover |
7.96 | 8.49 | 8.44 | 6.98 | 8.14 | 8.62 | 8.10 | 9.71 | 8.08 | 8.83 |
Accounts Payable Turnover |
6.99 | 6.88 | 5.69 | 6.80 | 10.34 | 10.94 | 11.72 | 15.31 | 11.41 | 9.05 |
Inventory Turnover |
4.01 | 3.83 | 3.13 | 3.62 | 4.69 | 3.85 | 3.85 | 4.79 | 3.91 | 3.85 |
Average Days of Payables |
58.11 | 39.76 | 54.28 | 66.88 | 39.08 | 28.71 | 33.56 | 28.32 | 35.14 | 34.84 |
Days of Inventory on Hand |
86.62 | 82.00 | 88.71 | 130.88 | 68.23 | 79.76 | 96.97 | 91.16 | 111.35 | 90.94 |
Average Receivables |
3.44 | 3.83 | 4.81 | 6.35 | 5.87 | 6.20 | 7.73 | 6.64 | 4.42 | 3.44 |
Average Payables |
3.06 | 3.62 | 5.35 | 4.95 | 3.38 | 3.50 | 3.70 | 2.87 | 2.12 | 2.22 |
Average Inventory |
5.33 | 6.50 | 9.74 | 9.30 | 7.45 | 9.95 | 11.26 | 9.19 | 6.20 | 5.21 |
Average Assets |
20.69 | 28.00 | 32.75 | 37.29 | 38.37 | 38.61 | 40.84 | 34.06 | 20.67 | 17.21 |
Average Common Equity |
0.73 | 7.53 | 11.30 | 15.63 | 14.33 | 10.12 | 9.42 | 6.78 | 2.85 | 2.73 |
Columns are period end dates